世界の中枢神経系治療薬市場予測2023-2029：OTC、Rx医薬品

【英語タイトル】Central Nervous System Drugs Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8404
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：78
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の中枢神経系治療薬市場規模と予測を収録しています。・世界の中枢神経系治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の中枢神経系治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の中枢神経系治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

中枢神経系治療薬のグローバル主要企業は、Biogen、 Pfizer、 Teva、 Novartis、 Johnson & Johnson、 EliLilly、 Otsuka、 Merck、 AstraZeneca、 Novartis、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、中枢神経系治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の中枢神経系治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の中枢神経系治療薬市場：タイプ別市場シェア、2022年
・OTC、Rx医薬品

世界の中枢神経系治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の中枢神経系治療薬市場：用途別市場シェア、2022年
・病院、小売薬局

世界の中枢神経系治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の中枢神経系治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における中枢神経系治療薬のグローバル売上、2018年-2023年
・主要企業における中枢神経系治療薬のグローバル売上シェア、2022年
・主要企業における中枢神経系治療薬のグローバル販売量、2018年-2023年
・主要企業における中枢神経系治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Biogen、 Pfizer、 Teva、 Novartis、 Johnson & Johnson、 EliLilly、 Otsuka、 Merck、 AstraZeneca、 Novartis、 Takeda

*************************************************************

・調査・分析レポートの概要
中枢神経系治療薬市場の定義
市場セグメント
世界の中枢神経系治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の中枢神経系治療薬市場規模
世界の中枢神経系治療薬市場規模：2022年 VS 2029年
世界の中枢神経系治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの中枢神経系治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の中枢神経系治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、Rx医薬品
中枢神経系治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局
中枢神経系治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別中枢神経系治療薬市場規模 2022年と2029年
地域別中枢神経系治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Biogen、 Pfizer、 Teva、 Novartis、 Johnson & Johnson、 EliLilly、 Otsuka、 Merck、 AstraZeneca、 Novartis、 Takeda
...

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Drugs. This report contains market size and forecasts of Central Nervous System Drugs in global, including the following market information:
Global Central Nervous System Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Central Nervous System Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Central Nervous System Drugs companies in 2022 (%)
The global Central Nervous System Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Central Nervous System Drugs include Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka, Merck and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Central Nervous System Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Nervous System Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Central Nervous System Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Central Nervous System Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Central Nervous System Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Global Central Nervous System Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Central Nervous System Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Central Nervous System Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Central Nervous System Drugs revenues share in global market, 2022 (%)
Key companies Central Nervous System Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Central Nervous System Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Central Nervous System Drugs, market overview.
Chapter 2: Global Central Nervous System Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Central Nervous System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Central Nervous System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Central Nervous System Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Central Nervous System Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Central Nervous System Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Central Nervous System Drugs Overall Market Size
2.1 Global Central Nervous System Drugs Market Size: 2022 VS 2029
2.2 Global Central Nervous System Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Central Nervous System Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Central Nervous System Drugs Players in Global Market
3.2 Top Global Central Nervous System Drugs Companies Ranked by Revenue
3.3 Global Central Nervous System Drugs Revenue by Companies
3.4 Global Central Nervous System Drugs Sales by Companies
3.5 Global Central Nervous System Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Central Nervous System Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Central Nervous System Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Central Nervous System Drugs Players in Global Market
3.8.1 List of Global Tier 1 Central Nervous System Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Central Nervous System Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Central Nervous System Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global Central Nervous System Drugs Revenue & Forecasts
4.2.1 By Type – Global Central Nervous System Drugs Revenue, 2018-2023
4.2.2 By Type – Global Central Nervous System Drugs Revenue, 2024-2029
4.2.3 By Type – Global Central Nervous System Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Central Nervous System Drugs Sales & Forecasts
4.3.1 By Type – Global Central Nervous System Drugs Sales, 2018-2023
4.3.2 By Type – Global Central Nervous System Drugs Sales, 2024-2029
4.3.3 By Type – Global Central Nervous System Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Central Nervous System Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Central Nervous System Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application – Global Central Nervous System Drugs Revenue & Forecasts
5.2.1 By Application – Global Central Nervous System Drugs Revenue, 2018-2023
5.2.2 By Application – Global Central Nervous System Drugs Revenue, 2024-2029
5.2.3 By Application – Global Central Nervous System Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Central Nervous System Drugs Sales & Forecasts
5.3.1 By Application – Global Central Nervous System Drugs Sales, 2018-2023
5.3.2 By Application – Global Central Nervous System Drugs Sales, 2024-2029
5.3.3 By Application – Global Central Nervous System Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Central Nervous System Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Central Nervous System Drugs Market Size, 2022 & 2029
6.2 By Region – Global Central Nervous System Drugs Revenue & Forecasts
6.2.1 By Region – Global Central Nervous System Drugs Revenue, 2018-2023
6.2.2 By Region – Global Central Nervous System Drugs Revenue, 2024-2029
6.2.3 By Region – Global Central Nervous System Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Central Nervous System Drugs Sales & Forecasts
6.3.1 By Region – Global Central Nervous System Drugs Sales, 2018-2023
6.3.2 By Region – Global Central Nervous System Drugs Sales, 2024-2029
6.3.3 By Region – Global Central Nervous System Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Central Nervous System Drugs Revenue, 2018-2029
6.4.2 By Country – North America Central Nervous System Drugs Sales, 2018-2029
6.4.3 US Central Nervous System Drugs Market Size, 2018-2029
6.4.4 Canada Central Nervous System Drugs Market Size, 2018-2029
6.4.5 Mexico Central Nervous System Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Central Nervous System Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Central Nervous System Drugs Sales, 2018-2029
6.5.3 Germany Central Nervous System Drugs Market Size, 2018-2029
6.5.4 France Central Nervous System Drugs Market Size, 2018-2029
6.5.5 U.K. Central Nervous System Drugs Market Size, 2018-2029
6.5.6 Italy Central Nervous System Drugs Market Size, 2018-2029
6.5.7 Russia Central Nervous System Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Central Nervous System Drugs Market Size, 2018-2029
6.5.9 Benelux Central Nervous System Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Central Nervous System Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Central Nervous System Drugs Sales, 2018-2029
6.6.3 China Central Nervous System Drugs Market Size, 2018-2029
6.6.4 Japan Central Nervous System Drugs Market Size, 2018-2029
6.6.5 South Korea Central Nervous System Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Central Nervous System Drugs Market Size, 2018-2029
6.6.7 India Central Nervous System Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Central Nervous System Drugs Revenue, 2018-2029
6.7.2 By Country – South America Central Nervous System Drugs Sales, 2018-2029
6.7.3 Brazil Central Nervous System Drugs Market Size, 2018-2029
6.7.4 Argentina Central Nervous System Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Central Nervous System Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Central Nervous System Drugs Sales, 2018-2029
6.8.3 Turkey Central Nervous System Drugs Market Size, 2018-2029
6.8.4 Israel Central Nervous System Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Central Nervous System Drugs Market Size, 2018-2029
6.8.6 UAE Central Nervous System Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Central Nervous System Drugs Major Product Offerings
7.1.4 Biogen Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Central Nervous System Drugs Major Product Offerings
7.2.4 Pfizer Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Central Nervous System Drugs Major Product Offerings
7.3.4 Teva Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Teva Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Central Nervous System Drugs Major Product Offerings
7.4.4 Novartis Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Central Nervous System Drugs Major Product Offerings
7.5.4 Johnson & Johnson Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 EliLilly
7.6.1 EliLilly Company Summary
7.6.2 EliLilly Business Overview
7.6.3 EliLilly Central Nervous System Drugs Major Product Offerings
7.6.4 EliLilly Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.6.5 EliLilly Key News & Latest Developments
7.7 Otsuka
7.7.1 Otsuka Company Summary
7.7.2 Otsuka Business Overview
7.7.3 Otsuka Central Nervous System Drugs Major Product Offerings
7.7.4 Otsuka Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Otsuka Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Central Nervous System Drugs Major Product Offerings
7.8.4 Merck Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Central Nervous System Drugs Major Product Offerings
7.9.4 AstraZeneca Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Central Nervous System Drugs Major Product Offerings
7.10.4 Novartis Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Central Nervous System Drugs Business Overview
7.11.3 Takeda Central Nervous System Drugs Major Product Offerings
7.11.4 Takeda Central Nervous System Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Takeda Key News & Latest Developments
8 Global Central Nervous System Drugs Production Capacity, Analysis
8.1 Global Central Nervous System Drugs Production Capacity, 2018-2029
8.2 Central Nervous System Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Central Nervous System Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Central Nervous System Drugs Supply Chain Analysis
10.1 Central Nervous System Drugs Industry Value Chain
10.2 Central Nervous System Drugs Upstream Market
10.3 Central Nervous System Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Central Nervous System Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Central Nervous System Drugs in Global Market
Table 2. Top Central Nervous System Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Central Nervous System Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Central Nervous System Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Central Nervous System Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Central Nervous System Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Central Nervous System Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Central Nervous System Drugs Product Type
Table 9. List of Global Tier 1 Central Nervous System Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Central Nervous System Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Central Nervous System Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Central Nervous System Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Central Nervous System Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Central Nervous System Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Central Nervous System Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Central Nervous System Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Central Nervous System Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Central Nervous System Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Central Nervous System Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Central Nervous System Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Central Nervous System Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Central Nervous System Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Central Nervous System Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Central Nervous System Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Central Nervous System Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Central Nervous System Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Central Nervous System Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Central Nervous System Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Central Nervous System Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Central Nervous System Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Central Nervous System Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Central Nervous System Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Central Nervous System Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Central Nervous System Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Central Nervous System Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Central Nervous System Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Central Nervous System Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Central Nervous System Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Central Nervous System Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Central Nervous System Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Central Nervous System Drugs Sales, (K Units), 2024-2029
Table 46. Biogen Company Summary
Table 47. Biogen Central Nervous System Drugs Product Offerings
Table 48. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Biogen Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Central Nervous System Drugs Product Offerings
Table 52. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Central Nervous System Drugs Product Offerings
Table 56. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Teva Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Central Nervous System Drugs Product Offerings
Table 60. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Central Nervous System Drugs Product Offerings
Table 64. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. EliLilly Company Summary
Table 67. EliLilly Central Nervous System Drugs Product Offerings
Table 68. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. EliLilly Key News & Latest Developments
Table 70. Otsuka Company Summary
Table 71. Otsuka Central Nervous System Drugs Product Offerings
Table 72. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Otsuka Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Central Nervous System Drugs Product Offerings
Table 76. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Central Nervous System Drugs Product Offerings
Table 80. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Central Nervous System Drugs Product Offerings
Table 84. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Takeda Company Summary
Table 87. Takeda Central Nervous System Drugs Product Offerings
Table 88. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Takeda Key News & Latest Developments
Table 90. Central Nervous System Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Central Nervous System Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Central Nervous System Drugs Production by Region, 2018-2023 (K Units)
Table 93. Global Central Nervous System Drugs Production by Region, 2024-2029 (K Units)
Table 94. Central Nervous System Drugs Market Opportunities & Trends in Global Market
Table 95. Central Nervous System Drugs Market Drivers in Global Market
Table 96. Central Nervous System Drugs Market Restraints in Global Market
Table 97. Central Nervous System Drugs Raw Materials
Table 98. Central Nervous System Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Central Nervous System Drugs Downstream
Table 100. Central Nervous System Drugs Downstream Clients in Global Market
Table 101. Central Nervous System Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Central Nervous System Drugs Segment by Type in 2022
Figure 2. Central Nervous System Drugs Segment by Application in 2022
Figure 3. Global Central Nervous System Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Central Nervous System Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Central Nervous System Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Central Nervous System Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Central Nervous System Drugs Revenue in 2022
Figure 9. By Type - Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Central Nervous System Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Central Nervous System Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Central Nervous System Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Central Nervous System Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 23. US Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 28. Germany Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 37. China Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Central Nervous System Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Central Nervous System Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Central Nervous System Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Central Nervous System Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Central Nervous System Drugs by Region, 2022 VS 2029
Figure 54. Central Nervous System Drugs Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界の中枢神経系治療薬市場予測2023-2029：OTC、Rx医薬品] (コード：MMG23LY8404)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の中枢神経系治療薬市場予測2023-2029：OTC、Rx医薬品]についてメールでお問い合わせ

MarketReport.jp

世界の中枢神経系治療薬市場予測2023-2029：OTC、Rx医薬品

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp